NCT03444012 - ADHERE-S (NIS Brilique) | Biotech Hunter

Enrollment

269

Participants

Timeline

Start Date

March 5, 2018

Primary Completion Date

August 13, 2019

Study Completion Date

August 13, 2019

Conditions

ACS (Acute Coronary Syndrome)

Interventions

DRUG

ticagrelor 90 mg

persistence and adherence on ticagrelor in ACS patients

Trial Locations (9)

CHC Bezanijska Kosa, Belgrade

CHC Zemun, Belgrade

CHC Zvezdara, Belgrade

Clinical Center of Serbia, Belgrade

Institute for cardiovascular diseases, Dedinje, Belgrade

Medical Military Academy, Belgrade

Institute for cardiovascular diseases of Vojvodina, Kamenitz

Clinical Center Kragujevac, Kragujevac

Clinical Center Nis, Niš